NCT05152550 is a clinical trial of Non-severe pre-eclampsia in Pre-Eclampsia, sponsored by Ahmed Nagy Abdul-Rahman Younis.

Who is sponsoring NCT05152550?

NCT05152550 is sponsored by Ahmed Nagy Abdul-Rahman Younis.

What drugs are being tested in NCT05152550?

Interventions in NCT05152550: Non-severe pre-eclampsia.

What condition does NCT05152550 study?

NCT05152550 studies Pre-Eclampsia.

Is NCT05152550 still recruiting?

NCT05152550 is currently status unknown. Last updated 29 December 2021.

Last reviewed 2021-12-29 · How we verify

NCT05152550

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Factors Predicting Transformation of Non Severe Pre-eclampsia Into Pre-eclampsia With Severe Features

Status unknown Last updated 29 December 2021

What this trial tests

trial testing Non-severe pre-eclampsia in Pre-Eclampsia in 1 participant. Status unknown.

Timeline

1 May 2021

Primary endpoint
1 March 2022

30 March 2022

Quick facts

Lead sponsor	Ahmed Nagy Abdul-Rahman Younis
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1
Start date	1 May 2021
Primary completion	1 March 2022
Estimated completion	30 March 2022
Sites	1 location across Egypt

Drugs / interventions tested

Non-severe pre-eclampsia

Conditions studied

Pre-Eclampsia — all drugs for Pre-Eclampsia →

Sponsor

Ahmed Nagy Abdul-Rahman Younis

Who can join

Adults 20 to 40, female only, with Pre-Eclampsia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Preeclampsia is a multi-system progressive disorder characterized by the new onset of hypertension and proteinuria, or hypertension and significant end-organ dysfunction with or without proteinuria, in the last half of pregnancy or postpartum. The genesis of the disease is laid down in early pregnancy and is characterized anatomically by abnormal remodeling of the maternal spiral arteries at the placental site.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pre-Eclampsia

Currently open trials in the same condition.

NCT07245056 — Fetal Fornix and Hippocampus in Pregnant Women With Early-Onset Preeclampsia · NA · recruiting
NCT07187596 — Mortality Outcome of Controlled Hypertension · active not recruiting
NCT06893510 — Virtual Reality-Based and Face-to-Face Relaxation Programs in Pregnant Women With Preeclampsia · NA · recruiting
NCT06122220 — Optic Nerve Sheath Measurement and Angiogenic Factors in Patients With Pre-eclampsia. · NA · recruiting
NCT06779916 — Autophagy/Apoptosis Balance in Placental Vascular Pathologies · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05152550 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ahmed Nagy Abdul-Rahman Younis
Last refreshed: 29 December 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05152550.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing